India slams Lancet on superbug

The superbug story fabricated by the hospitals and physicians in Britain came under direct lashing from Union Ministry of Health and Family Welfare when it sternly opposed to the claims made that drug-resistant superbug which causes multiple organ failure has its origin in India.

The government of India considered this statement as baseless, and it simply meant only to tarnish the image. In the latest issue of journal, The Lancet, scientists that the enzyme, named as New Delhi Metallo beta lactamase (NDM-1) is playing havoc as many of the Britains have got infected with the bug after they returned home from India. The patients who had otherwise stayed in India for month or more have contracted superbug. The publication said that the NDM-1 can play havoc across the globe, and the amazing thing to note is that enzyme is resistant to many types of drugs.

On the basis of reports emerging, national resistance alert was issued in July 2009 in UK hospitals. Later, similar reports have also started coming from Israel, USA, Greece and Scotland.

The Union Ministry of Health and Family Welfare on the other hand clearly pointed out that the report published in the journal showcased conflict of interests as European Union and the two pharma companies named Wellcome Trust and Wyeth, had funded the entire study. Reacting further on the reports, Union Ministry of Health and Family Welfare that hospitals in India are completely safe.  The ministry also quoted that India is a safe place to visit, and reports like these are meant to destabilize phenomenally growing medical tourism sector.